Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts

Author：                  

Publisher： Spandidos Publications

E-ISSN： 1791-2431|33|5|2135-2142

ISSN： 1021-335X

Source： Oncology Reports, Vol.33, Iss.5, 2015-01, pp. : 2135-2142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and efficacy of panitumumab therapy after metastatic colorectal cancer progression with cetuximab: Experience at a single Japanese institution

By          

Oncology Letters, Vol. 5, Iss. 4, 2013-01 ,pp. : 1331-1334

Spandidos Publications

Access to resources Recommend Favorite

Bevacizumab in combination with cetuximab and irinotecan after failure of cetuximab and irinotecan in patients with metastatic colorectal cancer

By Larsen Finn Ole   Pfeiffer Per   Nielsen Dorte   Skougaard Kristin   Qvortrup Camilla   Vistisen Kirsten   Fromm Anne-Lene   Jøørgensen Trine L.   Bjerregaard Jon K.   Hoegdall Estrid   Jensen Benny V.  

Acta Oncologica, Vol. 50, Iss. 4, 2011-05 ,pp. : 574-577

Informa Healthcare

Access to resources Recommend Favorite

Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice

By Allegrini Giacomo   Goulette Frederick   Darnowski James   Calabresi Paul  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 3, 2004-03 ,pp. : 261-266

Springer Publishing Company

Access to resources Recommend Favorite

Combination therapy using oral S-1 and targeted agents against human tumor xenografts in nude mice

By                    

Experimental and Therapeutic Medicine, Vol. 3, Iss. 5, 2012-01 ,pp. : 755-762

Spandidos Publications

Access to resources Recommend Favorite

Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur

By Watanabe Masahiko   Nishida Osamu   Kunii Yasuo   Kodaira Susumu   Takahashi Takashi   Tominaga Takeshi   Hojyo Keiichi   Kato Tomoyuki   Niimoto Minoru   Kunitomo Kazufumi   Isomoto Hiroyasu   Ohashi Yasuo   Yasutomi Masayuki  

International Journal of Clinical Oncology, Vol. 9, Iss. 2, 2004-04 ,pp. : 98-106

Springer Publishing Company

Access to resources Recommend Favorite